Lv11
88 积分 2023-12-11 加入
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
6小时前
待确认
Targeting the tumour cell surface in advanced prostate cancer
1个月前
已完结
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape
4个月前
已完结
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
6个月前
已完结
From biology to the clinic — exploring liver metastasis in prostate cancer
6个月前
已完结
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
10个月前
已完结
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
10个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1年前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1年前
已完结
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
1年前
已完结
Improving physical activity among older adults with intellectual disabilities by a structured day care program
6小时前
已采纳
New national cancer registry for France
6小时前
已采纳
The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation
1年前
已采纳
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
1年前
已采纳
皖公网安备34019202002308
